Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation Close
Home
  • BioJet Platform
  • Publications
  • About Us
  • News
Toggle the search bar
Close the mobile navigation

Publications

Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJetâ„¢ oral biotherapeutic delivery platform in a porcine model: an update
October 4, 2023 #BioJet Oral Therapeutic Delivery
Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJetâ„¢ oral biotherapeutic delivery platform in a porcine model
June 23, 2023 #BioJet Oral Therapeutic Delivery
Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
October 23, 2022 #BioJet Oral Therapeutic Delivery
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
October 23, 2022 #BioJet Oral Therapeutic Delivery
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
October 18, 2022 #BioJet Oral Therapeutic Delivery

Connect with us

Email Us Biora Therapeutics Linkedin
  • Platforms

    BioJet Oral Therapeutic Delivery NaviCap Targeted Therapeutic Delivery

    Publications

    BioJet Publications NaviCap Publications
  • About Us

    News

  • Connect with Us

    Email Us Biora Therapeutics Linkedin
Privacy Accessibility

© 2026 BT Bidco Inc., dba Biora Therapeutics. All rights reserved. Biora Therapeutics and BioJet are trademarks of BT Bidco, Inc.

Precaution: investigational drug/device combination products. Currently limited by Federal law to investigational use only. Not for sale in the U.S.